Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients

Abstract

To compare the performance of different commercial anti-dsDNA autoantibody assays, including multiplex-based immunoassay (Bio-Plex), Farr radioimmunoassay (Farr), ELISA, chemiluminescent immunoassay (CLIA), and Crithidia Luciliae indirect immunofluorescence test (CLIFT) in Chinese patients with systemic lupus erythematosus (SLE). SLE patients (n = 119) as well as healthy controls (n = 200) and disease controls (n = 100) were recruited, and serum anti-dsDNA autoantibodies were detected by Bio-Plex, Farr, two ELISA assays (Medical & Biological Laboratories-ELISA, EUROIMMU-ELISA), CLIA, and a standard CLIFT. The correlation of anti-dsDNA autoantibody levels to SLE disease activity was calculated, and the specificity and sensitivity of these methods were measured by receiver-operator characteristic (ROC) curve analysis. In ROC curve analysis, Bio-Plex showed the largest area under the curve (AUC) over other assays. Cutoff adjustment according to ROC enhanced the performance of all quantitative assays. Overall, Bio-Plex and CLIFT have higher specificity (>90.00%). ELISA and CLIA results are correlated with disease activity, and Bio-Plex results have the strongest correlation with SLEDAI score and active renal involvement. Bio-Plex assay has better overall performance in anti-dsDNA detection over Farr, ELISA, and CLIA methods in Chinese SLE patients.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10067-017-3771-x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 21 references

Cited by

See all 22

Metadata

Authors
Zhao, J., Wang, K., Wang, X., Li, T., Guo, L., Gu, L., Chen, Z., Sun, F., Wang, H., Li, J., Huang, J., Zhang, P., Tang, Y., & Ye, S.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Ye, Shuang
Venue
Clinical Rheumatology
Published
2017-07-25
Volume
37
Issue
1
Pages
139-144
ISSN
  • 0770-3198 (ISSN-L)
  • 1434-9949
OpenAlex
W2739431617
Cited by
22
References
21
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 3 · 2019: 1 · 2018: 3
FWCI
0.96
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Rheumatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81601402)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
anti-dsDNA antibodies, systemic lupus erythematosus, assay performance comparison, ELISA, chemiluminescence immunoassay, sensitivity and specificity, SLE disease activity, SLEDAI, renal involvement, Chinese patients
MeSH terms
Autoantibodies, China, DNA, Female, Humans, Lupus Erythematosus, Systemic, Male, Sensitivity and Specificity, Severity of Illness Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients. https://app.cochat.ai/papers/10.1007/s10067-017-3771-x
The paper
Zhao, J., Wang, K., Wang, X., Li, T., Guo, L., Gu, L., Chen, Z., Sun, F., Wang, H., Li, J., Huang, J., Zhang, P., Tang, Y., & Ye, S. (2018). The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients. Clinical Rheumatology. https://doi.org/10.1007/s10067-017-3771-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.